Corvia Medical
Pre-clinicalThe Corvia® Atrial Shunt is designed to reduce symptoms associated with heart failure (HF), reduce HF hospitalizations, and improve quality of life.
Founded
2009
Focus
Medical DevicesCardiovascular
About
The Corvia® Atrial Shunt is designed to reduce symptoms associated with heart failure (HF), reduce HF hospitalizations, and improve quality of life.
Funding History
3Total raised: $207M
Series C$80MRA Capital ManagementDec 15, 2020
Series B$92MGeneral CatalystMay 15, 2018
Series A$35MThird Rock VenturesJun 15, 2015
Company Info
TypePrivate
Founded2009
LocationTewksbury, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile